Patients who achieved HIV virologic suppression tended to be older and were more likely to report continued engagement in HIV care than those with persistent viremia.

The Institute of Science and Technology for Brain-Inspired Intelligence at Fudan University announced that it will establish ...

Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot, lenacapavir, for $40 (around R692) per person per ...

A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between producers and key HIV/AIDS prevention programme ...

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage - NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections ...

The White House details its Gaza peace deal plan. No breakthrough after Trump’s meeting with Democrats to avert a government ...

America-first global health strategy focuses on containing infectious disease outbreaks before they hit the US.

That led to a lifelong struggles with severe joint damage, atrophied legs and a diagnosis of HIV after a blood transfusion. Medical treatment allowed him to stop using a wheelchair at 16, but he still ...

According to the World Health Organization (WHO), lenacapavir offers a highly effective, long-acting alternative to daily ...

Tarava’s story illustrates the remarkable progress Zimbabwe has made in tackling the HIV crisis. Once ravaged by soaring ...

Discover Immuneering’s latest breakthrough: atebimetinib delivers unprecedented survival rates in first-line pancreatic cancer.